Case Activity (11846)

1. Order | Filed: July 17, 2026 | Entered: July 17, 2026 Regeneron Pharmaceuticals, Inc. v. Sanofi Biotechnology SAS et al

   Contract: Other | New York Southern

   Scheduling Order

   REVISED CIVIL CASE DISCOVERY PLAN AND SCHEDULING ORDER: All parties do not consent to conducting all further proceedings before a Magistrate Judge, including motions and trial, pursuant to 28 U.S.C. § 636(c). This case is to be tried to a jury. Non-expert depositions shall be completed by November 17, 2026.The parties have conferred and their present best estimate of the lenght of the trial is 1 week. Deposition due by 2/4/2027. Fact Discovery due by 11/17/2026. Expert Discovery due by 2/4/2027. Discovery due by 2/4/2027. Case Management Conference set for 2/17/2027 at 02:30 PM before Judge Philip M. Halpern. SO ORDERED. (Signed by Judge Philip M. Halpern on 7/17/2026) (jca)

2. Order | Filed: July 17, 2026 | Entered: July 17, 2026 Regeneron Pharmaceuticals, Inc. v. Sanofi Biotechnology SAS et al

   Contract: Other | New York Southern

   Order on Motion for Extension of Time to Complete Discovery

   ORDER granting 91 Letter Motion for Extension of Time to Complete Discovery. Application granted. A revised Civil Case Discovery Plan and Scheduling Order will be separately docketed. The case management conference scheduled for December 2, 2026 is adjourned to February 17, 2027 at 2:30 p.m. The Clerk of Court is respectfully requested to terminate the letter-motion pending at Doc. 91. SO ORDERED.. (Signed by Judge Philip M. Halpern on 7/17/2026) (jca)

3. 11844 additional result(s)